NCT06930612View on ClinicalTrials.gov

A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1）

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

September 16, 2026

Study Completion Date

September 16, 2026

Conditions
Chronic Rhinosinusitis With Nasal Polyposis
Interventions
BIOLOGICAL

CM512

Administered subcutaneous injection

DRUG

Placebo

Administered subcutaneous injection

Trial Locations (1)

Unknown

Beijing Tong-Ren hospital, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06930612 - A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1） | Biotech Hunter | Biotech Hunter